<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 352 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page351.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=352">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 352 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 352</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=352"><img src="../thumb/352.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Endocrine System / Vitamins, Tonics, Minerals and Electrolytes - 19.8 / 20 / 20.1  2020-04 / 315
       Warnings and special precautions: Mod.to sev. hepat.impairm.,   left ventr.eject.fract.&lt;50% /NYHA Class III or IV HF not est., hyper-  Indications: Pernic.anaem.& its neurolog. complicats., subac.
       per.liv.funct.monit.dur. longt. ther., discont.ther.if hepat.chang.sev.,   tens.contr./hypokalaem.correct. bef.init.ther., concom.corticoster.re-  combin.spin.cord.degenerat., defic.states, macrocyt.anaem.as-
       monit. prothromb.time with warfar.  duc.severit.of hypertens./ hypokalaem.& fluid retent., monit.BP/ ser.  soc.with nutrit. defic., megaloblast.anaem.& neurologic.condits.,
                                     +
       Drug interactions: Concom.meds.may inhib. oxidat. eg. ketocona-  K /fluid retent.at least mnthly., ser.transamin. lev./ bilirub.to be meas.  intest.malabsorpt., megaloblastos., diet relat.defic, post gastrec-
       zole & cimetidine which poss. incr. plasma conc., midazolam AUC   bef.init.treatm.& every 2 wks.for 1st 3 mnths.of treatm.and mnthly   tomy. Prophylax.indicat.incl.strict vegetarian., post gastrect. & ileal
       incr., poss. displac. warfar.from its prot.bind.sites.  thereaft., withdr. ther.immed.if S&S suggest.of sev. hepatotox. de-  resect.& condits. of small intest.that would predictably cause defic.
       TEVA ANASTROZOLE, (Cipla Medpro) Teva  vel.& LFT to be meas.immed., ther.to be interrupt.& liv.funct.monit.if   (S3) INJ. H2413, H2635. 1 000 µg/ml.
                                                                  776548-018: 10x1 ml amps, R78,41
       Anastrozole.                  LFT &gt; 5x norm. limit/ bilirub.3x norm.limit, retreat only aft.LFT return   776556-053: 10x10 ml vials, R184,87
                                     to baseline aft.which reduc.dos.may be giv., no re-challenge if sev.
       Indications: Advanc.breast Ca in postmenopaus. women. Effic.not   Dosage: Admin.IM.
       demonstrat.in oestrog.recept. negat.pts.unless prev.posit.clinic.re-  hepatoxic.occurs, no data on multiple dos.admin.in mod.or sev.hepat.  Without neurolog.involvem: 250-1 000 µg on alt.days x1-2
       spons.to tamoxifen report.    impairm., monit. for adrenocort. insuff.if prednisolone/ prednisone   wks. Then 250 µg wkly until bld.count returns to norm. Maint:
       (S4) TABS. 42/21.12/0760      withdr. & ther.contin., incr.corticoster. dos. poss.indic.bef./dur./aft.  1000 µg mnthly.
       718266-001: 1 mg, 30, R236,94  stressf.situat.in case pts. on prednisone/ prednisolone are subj.to   With neurolog.involvem: 1 000 µg on alt.days contin.for as long
       Dosage: 1 tab.once dly.       unusual stress, safety & effic.with concom.cytotox. chemother. not   as improvem.occurs.
       Contraindications: Pre-menopaus.women, pregn. & lactat., sev.  est., lact.intol., avoid other strong CYP3A4 induc., concom.meds.ac-  Anaem.assoc.with vit.B12 defic.prophylax: 250-1 000 µg
       ren.impairm., mod.to sev. hepat. dis.  tiv./metab.by CYP2D6 esp.meds.with narr.therap.index., monit. for   mnthly.
       Side effects: Hot flush., periph.oed., flush., asthen., pelv./back/  toxic.signs relat.to concom.CYP2C8 substrates with narr.therapeut.  Contraindications: Megloblast.anaem.of pregn., IV admin., toxic
       chest/ bone/ breast pain, anorex., incr.appet., hair thin., rash, sweat.,   index, concom. spironolactone not recomm., no data relat.to concom.  amblyop.treatm., prem.babies/ neonates.
       GI disturbs., headache, dizzin., depress., dyspn., cough, pharyngit.,   eplenerone, pregn./ potent.pregn.women incl.healthcare profess.   Side effects: Allerg.reacts., react.thrombocytos., hypokalaem., skin
       hypertens., vag.dryn./bleed., weight gain, hypercholesterolaem.,   to handle with gloves, condom use/other effect. contracept.reqd.if   reacts., dizzin., trem., card. dysrhythm., GI disturbs., inj.site reacts.
       somnol., insomn., nervous., paraesthes., anx., confus., anaem.,   pt.sex.activ.with a pregn. woman/ women of childbear.potent.un-  Special precautions: Prophylact.admin.only when reason.indi-
       leucopen.with/without infect., thrombo-embol./phlebit., erythema   til 1 wk.aft. last dos., reduc.fertility reversib.in 4-16 wks.report. in   cat., dos.&gt;10 µg dly.may produc. haematolog.respon.in folate defic.,
       multiforme, Stev.John. syndr., allerg.skin reacts., angioed., anaphy-  male & female rats., bef.init.treatm.store semen of male pts. wish.  monit.long. term.ther at 6-12 mnthly interv.& 3-6 mnthly if condit.
       lax., bronchit., sinusit., rhinit., flu-like syndr, myalg., arthralg., joint   to father childr., incr.system. expos. if giv.with food.  poss.req.dos.adjustm.
       pain/ stiffn., bone fract.    Interactions: Safety & effic.if admin.with food not est., strong   Drug interactions: OC’s decr.ser.conc., large dos.folic acid reduc.
       Warnings and special precautions: Childr., poss.bone min.  CYP3A4 induc.decr.mean plasma AUC, incr.dextromethorphan/pi-  bld.conc., inactivat.by prolong. nitrous oxide anaesthes., vit.C may
       dens.reduct.with incr.fract.risk, biochem.confirmat.of menopause   oglitazone AUC., spironolactone binds to the androg.recept.& may   destroy vit B 12, poss.poor respons.with chloramphenicol
       if in doubt., lact.intol.     incr. prostate specif.antigen (PSA) lev.
       Drug interactions: Concom.tamoxifen &/other oestrog. contain.   See also MDR page 438.  ASCORBIC ACID FRESENIUS 500 mg/5 ml AMP,
       ther.dimin.pharm.act.                                      Fresenius Kabi [P/S]
                                                                  Vit.C.
       TEVA BICALUTAMIDE, (Cipla Medpro) Teva [P/S]               Indications: Sev.defic.states where oral admin. not poss.
       Bicalutamide.                 20     VITAMINS, TONICS,     (S3) INJ. H2473. 500 mg/5 ml.
       Indications: Advanc.prostate Ca in combin.with LHRH analogue   705071-006: 10x5 ml amps, R159,01
       ther./surg.castrat.                  MINERALS AND          Dosage: Therapeut: Adults: 200-600 mg dly. IM./IV/SC
       (S4) TABS. ,43/21.12/0764                                  Prophylact: 25-75 mg dly. Childr.up to 5 yrs: 50 mg dly.
       716660-001, 50 mg, 30, R604,06                             Contraindications: Hyperoxalur., ren.Ca oxalate calculi format.
       Dosage: Begin 3 days bef.LHRH ther./same time as surg.castrat.  ELECTROLYTES
       Adult males incl.elderly: 50 mg once dly.                  BE-TABS ASCORBIC ACID, Ranbaxy [P/S]
       (S4) TABS. ,43/21.12/0765                                  Ascorbic acid. Sugar free.
       Indications: In loc.advanc.prostate Ca as immed. ther.alone or  20.1  Vitamins  Indications: Ascorb.acid defic.esp.frank scurvy.
       as adjuv.to radical prostatect./ radiother., monother.of loc.advan.  (S0) TABS, T1211
       non-metastat. prostate Ca where surg/medic.castrat.not appropr.  A-LENNON CALCIFEROL, (Aspen Pharmacare: Pharma)   798487-003: 500 mg, 1 000, R376,26.
       716661-001, 150 mg, 30, R3 055,46  Pharmacare [P/S]        Dosage: 500 mg 2xdly aft.meals. Max: 1 000 mg/ day.
       Dosage: Adult males incl.elderly: 150 mg once dly.x2 yrs./  Ergocalciferol 1,25 mg equiv.to Vit.D 50 000 IU  Contraindications: Hyperoxalur.
       until progress.               Indications: Rickets, osteomalac., hypoparathyroid.  Side effects: Diuret.act.with dos.exceed. 600 mg/day.
       Contraindications: Fem., childr., pregn.& lactat.  (S3) TABS. H2053  Special precautions: Hyperoxalur., poss.tol.with high dos.
       Side effects: Asthen., hot flush., headache, fev., chills, abdom.&   711640-009: 50,000 IU, 100, R308,54  BE-TABS FOLIC ACID 5 mg, Ranbaxy [P/S]
       chest pain, thrombocytopen., anaem., leucopen., neutropen., hy-  Dosage: Rickets & osteomalac: 1 tab (50 000 IU) dly.  Folic acid
       pertens., angina, HF, conduct.irreg.incl.PR & QT-interv.prolongat.,   Hypoparathyroid: 1-4 tabs.50 000-200 000 IU)dly.  Indications: Prophylax.& treatm.of megaloblast. anaem.
       dysrhythm., non-specif. ECG changes, gynaecomast., decr.libido,   Contraindications: Hypercalcaem., pregn.& lactat.  (S1) TABS, T1205
       ment.depress., nervousn., dizzin., confus., drowsin., insomn., GI   Side effects: Hypercalcaem.incl.hypercalciur./ ectop. calcific./  810967-015: 5 mg, 100, R67,35
       disturbs., GI/rect. bleed., oed., diab.mellit, hyperglycaem., appe-  ren.& CV damage.  810967-006: 5 mg, 1 000, R673,80
       tite loss, musc.weakn., neuromusc. sympts., impot., noctur., hepat.   Warnings and special precautions: Infts., imp. ren. funct./calcul.,   810967-014: 5 mg, 5 000, R3 369,01
       disords., prurit., dry skin, skin rash/itch., alopec., sweat., hirsut.,   heart dis., those at incr.risk/ organ damage if hypercalcaem.occur.,   Dosage: Megaloblastic anaem.treatm: Init.10-20 mg dly x14
       runny nose, sore throat, dyspn., tight chest, flu-like syndr., infect.,   plasma phosph. conc. contr., adeq.intake through diet/ sunlight ex-  days. Maint: 2,5-10 mg. Megaloblastic anaem.of pregn.prophy-
       dry mouth, pulm.disord        pos., diab.mellit., lact.intol. cont. sucrose  lax: 200-500 mcg dly.
       Warnings and special precautions: Metabol. delay.in mod.to   Interactions: Reduc.eff.with barbits./anticonvuls.  Contraindications: Admin.alone/with inadeq. concom. hydroxo-
       sev.hepat.impairm.result.in prolong. eliminat.& incr.risk of side effs.,   cobalam.for megaloblast/ pernicious anaem.
       period. liv.funct.tests., concom.meds.metabol.by cytochrome P450,   A-LENNON-VIT B COMPLEX INJECTION, (Aspen Pharma-
       monit.prothromb.time with concom. coumar.anticoags., lact.intol.  care: Pharma) Pharmacare [P/S]  CALCIFEROL OILY SOLUTION LENNON, (Aspen Pharma-
       Drug interactions: Concom.meds.poss.inhib. oxidat. of agent   Vit.B1 10 mg, Vit.B2 2 mg, nicotinamide 100 mg, Vit.B6 5 mg, d-  care: Pharma ) Pharmacare [P/S]
       eg.ketoconazole & cimetidine could incr.plasma conc., poss.displac.  Panthenol 5 mg/ml.  Calciferol.
       warfar.from prot. bind.sites, incr.midazolam AUC when co-admin.  Indications: Diet supplem.  Indications: Nutrit.rickets, metabol.rickets, osteomalacia, hy-
                                                                  poparathyroid.
       ZYTIGA, Janssen Pharmaceutica [P/S] &  (S3) INJ. H2412, H2975  (S3) SOL. T1101. 0,125 mg/ml (equiv.to Vit.D 5 000 IU/ml)
       Abiraterone acetate           778141-004: 10x2 ml amps, R69,19  711853-010: 15 ml, R75,29
       Indications: In combinat.with low dos. corticoster. (prednisone/   776645-064: 10x10 ml vials, R164,45  Dosage:
       prednisolone) in adult men for treatm of high-risk metastat.hor-  Dosage: Amps: IM/slow cautious IV  Nutrit.rickets treatm: Minim.dly.dos 1 000 u (0,2 ml), but usuall.
       mon. treatm. naive prostate Ca/newly diagnos.high-risk metastat.   Vial: IM use only.  3 000-4 000 u (0,6-0,8 ml) dly.for rapid heal.
       hormon,sensit.prostate Ca in combinat. with androg.deprivat.ther.,   Recomm.dos: 1-2 ml dly.  Metabol.rickets & osteomalac: 10 000-50 000 u (2-10 ml)
       asymptomat./mild. symptomat. metastat.castrat.resist.prostate Ca   A-LENNON-VITAMIN B12, (Aspen Pharmacare: Pharma)   or more dly.
       with bone metastas.aft.androg.deprivat.ther.fail. where chemother   Pharmacare [P/S]  Hypoparathyroid: 50 000-100 000 u (10-20 ml) dly.poss.reqd.
       not yet clinic.indicat., metastat. advanc. prostate Ca who have prev.  Vit.B12. (Cyanocobalamin)  Contraindications: Hypercalcaem., safety in pregn.not est., lac-
       recd. chemother. cont.docetaxel                            tat., poss.congenit.disords. & neonat.hypoparathyroid. with hyper-
       (S4) TABS. 46/21.12/0379                                   calcaem.in pregn.
       720690-001: 250 mg, 120, R29 750,36  When adverse reactions or side   Side effects: Hypercalcaem.with excess.intake,
       Dosage: Admin.at least 2 hrs.aft.eat. No food to be eat.for at least   Special precautions: Effs.reduc.in pts.tak.barbit. /anticonvuls.,
       1 hr aft.admin. Swall.whole with water.  effects, e.g. fatigue, sedation,   incr.sens.in infts., ren.impairm., incr. organ. damage risk in heart
       Recomm: 1 g (4x250 mg tabs) as sngl.dly.dos. Cont.ther.until ra-  impaired psychomotor function   dis.if hypercalcaem. develop., monit.plasma phosph.conc.to reduc.
       diograph./clinic./PSA progress. Miss.dos: resume treatm.follow.  ectop. calcificat.risk, adeq.vit D intake through diet & UV expos.
       day with usual dly.dos.        and visual disturbances have been   LITHA-THIAMINE, Litha [P/S]
       Concom.prednisone/prednisolone: For metastat. hormon.naive
       prostate Ca or hormon, sensit. prostate Ca: 5 mg prednisone/ pred-  reported, patients should be advised   Vit.B1.
                                                                  Indications: Beri-beri, vit.B1 defic.states.
       nisolone once dly. For metastat.castrat. resist.prostate Ca: 10 mg   not to engage in any activity which   (S0) TABS. H2034.
       prednisone/ prednisolone once dly.                         770493-009: 100 mg, 100, R59,78
       Contraindications: Pregn./potent.pregn., lactat., mod.to sev.hepat.  requires alert motor and other skills,   Dosage: 25-100 mg dly.
       impairm., use in women, concom. rifampicin  such as driving, operating machinery
       Side effects: Hypertens., hypokalaem., fluid retent./ periph.oed.,   RESCUVOLIN, (Cipla Medpro) Teva [P/S]
       UTI, sepsis, adren.insuff., hypertriglyceridaem., card.fail., ang.pect,   or climbing dangerous heights until   Folinic acid.
       atrial. fibrillat., tachycard., dysrhythm., diarrh., dyspeps., incr.aspar-  they know how the medication   Indications: Antidote to folic acid antagonists.
       tate aminotransferase/alanine aminotransferase, rash, myopathy,   (S0) TABS, S/22.1.4/339.
       rhabdomyolys., fract., haematur., hepatotox., MI, QT prolongat., al-  affects them, or are instructed by their   788503-006: 15 mg, 10, R244,18
       lerg. alveolit., fulminant hepatit., ac.hepat.fail.  treating clinician not to do so.  Dosage: Folinic acid rescue: Admin.up to 24 hrs. aft. methotrex:
       Warnings and special precautions: Underly. med. condits.poss.  up to 120 mg over 12-24 hrs.by IMI or IVI or IV infus., follow.by 12-
       comprom.by incr.BP/ hypokalaem. /fluid retent., CV dis.hist., safety in   15 mg IM or 15 mg orally 6 hrly x48 hrs.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page351.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page347.html">347</a>&nbsp;&nbsp;&nbsp;<a href="page348.html">348</a>&nbsp;&nbsp;&nbsp;<a href="page349.html">349</a>&nbsp;&nbsp;&nbsp;<a href="page350.html">350</a>&nbsp;&nbsp;&nbsp;<a href="page351.html">351</a>&nbsp;&nbsp;&nbsp;<a href="page352.html">352</a>&nbsp;&nbsp;&nbsp;<a href="page353.html">353</a>&nbsp;&nbsp;&nbsp;<a href="page354.html">354</a>&nbsp;&nbsp;&nbsp;<a href="page355.html">355</a>&nbsp;&nbsp;&nbsp;<a href="page356.html">356</a>&nbsp;&nbsp;&nbsp;<a href="page357.html">357</a>
             </td>
             <td width="35%"><a href="page353.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page353.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
